Aeson Chang

560 total citations
18 papers, 324 citations indexed

About

Aeson Chang is a scholar working on Psychiatry and Mental health, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Aeson Chang has authored 18 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Neurology. Recurrent topics in Aeson Chang's work include Cancer, Stress, Anesthesia, and Immune Response (12 papers), Vagus Nerve Stimulation Research (4 papers) and Neuropeptides and Animal Physiology (4 papers). Aeson Chang is often cited by papers focused on Cancer, Stress, Anesthesia, and Immune Response (12 papers), Vagus Nerve Stimulation Research (4 papers) and Neuropeptides and Animal Physiology (4 papers). Aeson Chang collaborates with scholars based in Australia, United States and Norway. Aeson Chang's co-authors include Erica K. Sloan, Adam K. Walker, Alexandra I. Ziegler, Cindy K. Pon, Michelle L. Halls, Caroline P. Le, Edoardo Botteri, Sarah J. Creed, J. Robert Lane and Bernhard Riedel and has published in prestigious journals such as Neuron, Nature reviews. Cancer and PLoS ONE.

In The Last Decade

Aeson Chang

18 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aeson Chang Australia 9 177 88 74 73 53 18 324
Itay Ricon‐Becker Israel 6 205 1.2× 45 0.5× 115 1.6× 55 0.8× 42 0.8× 14 371
Vincent Law United States 7 86 0.5× 81 0.9× 65 0.9× 105 1.4× 63 1.2× 21 401
Bertrand R. Huber United States 10 44 0.2× 40 0.5× 57 0.8× 84 1.2× 38 0.7× 14 377
Kate K. O’Toole United States 11 49 0.3× 183 2.1× 46 0.6× 169 2.3× 49 0.9× 14 473
Yangyang Feng China 12 97 0.5× 35 0.4× 94 1.3× 360 4.9× 74 1.4× 20 731
Anna Zinger Australia 8 79 0.4× 39 0.4× 16 0.2× 156 2.1× 23 0.4× 8 448
Barbara Pijet Poland 10 45 0.3× 86 1.0× 35 0.5× 198 2.7× 12 0.2× 12 404
Nikoletta Dobos Hungary 7 52 0.3× 21 0.2× 115 1.6× 139 1.9× 28 0.5× 15 466
Arnold E. Eggers United States 8 51 0.3× 69 0.8× 36 0.5× 78 1.1× 12 0.2× 28 317
Amy DeLuca United States 7 133 0.8× 58 0.7× 63 0.9× 27 0.4× 34 0.6× 15 397

Countries citing papers authored by Aeson Chang

Since Specialization
Citations

This map shows the geographic impact of Aeson Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aeson Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aeson Chang more than expected).

Fields of papers citing papers by Aeson Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aeson Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aeson Chang. The network helps show where Aeson Chang may publish in the future.

Co-authorship network of co-authors of Aeson Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Aeson Chang. A scholar is included among the top collaborators of Aeson Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aeson Chang. Aeson Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Botteri, Edoardo, Fabio Conforti, Vincenzo Bagnardi, et al.. (2025). Aprepitant use during chemotherapy and association with survival in women with early breast cancer. JNCI Journal of the National Cancer Institute. 117(11). 2249–2258. 2 indexed citations
2.
Amit, Moran, Tuany Eichwald, A. Roger, et al.. (2025). Neuro-immune cross-talk in cancer. Nature reviews. Cancer. 25(8). 573–589. 8 indexed citations
3.
Sloan, Erica K. & Aeson Chang. (2025). Wired to spread: Neural regulation of metastasis. Neuron. 113(17). 2726–2728. 1 indexed citations
4.
Sloan, Erica K., et al.. (2024). The sympathetic nervous system shapes the tumor microenvironment to impair chemotherapy response. Frontiers in Oncology. 14. 1460493–1460493. 3 indexed citations
5.
Dubowitz, Julia, Alexandra I. Ziegler, Richard Beare, et al.. (2023). Type of anesthesia for cancer resection surgery: No differential impact on cancer recurrence in mouse models of breast cancer. PLoS ONE. 18(11). e0293905–e0293905. 1 indexed citations
6.
Støer, Nathalie C., Erica K. Sloan, Aeson Chang, et al.. (2022). β-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis. British Journal of Cancer. 127(6). 1086–1096. 36 indexed citations
7.
Phillips, Andrew J. K., et al.. (2022). Disrupting circadian rhythms promotes cancer-induced inflammation in mice. Brain Behavior & Immunity - Health. 21. 100428–100428. 18 indexed citations
8.
Chang, Aeson, et al.. (2022). Biobehavioral Pathways and Cancer Progression: Insights for Improving Well-Being and Cancer Outcomes. Integrative Cancer Therapies. 21. 1553411217–1553411217. 28 indexed citations
9.
Chang, Aeson, et al.. (2021). Doxorubicin sensitizes breast cancer cells to stress signaling. Brain Behavior and Immunity. 98. 9–9. 1 indexed citations
10.
Botteri, Edoardo, Aeson Chang, Alexandra I. Ziegler, et al.. (2021). Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients. European Journal of Cancer. 147. 106–116. 50 indexed citations
11.
Chang, Aeson, et al.. (2020). The Anti-Inflammatory Drug Aspirin Does Not Protect Against Chemotherapy-Induced Memory Impairment by Paclitaxel in Mice. Frontiers in Oncology. 10. 564965–564965. 14 indexed citations
12.
Frederickson, Andrew M., et al.. (2019). PCN468 SYSTEMATIC REVIEW OF UTILITY ESTIMATES IN TRIPLE-NEGATIVE BREAST CANCER PATIENTS. Value in Health. 22. S527–S528. 1 indexed citations
13.
Frederickson, Andrew M., et al.. (2019). PCN132 SYSTEMATIC REVIEW OF ECONOMIC BURDEN IN TRIPLE-NEGATIVE BREAST CANCER PATIENTS. Value in Health. 22. S461–S461. 1 indexed citations
14.
Alcobia, Diana C., Alexandra I. Ziegler, Alexander Kondrashov, et al.. (2018). Visualizing Ligand Binding to a GPCR In Vivo Using NanoBRET. iScience. 6. 280–288. 25 indexed citations
15.
Walker, Adam K., Aeson Chang, Alexandra I. Ziegler, et al.. (2018). Low dose aspirin blocks breast cancer-induced cognitive impairment in mice. PLoS ONE. 13(12). e0208593–e0208593. 30 indexed citations
16.
Walker, Adam K., Aeson Chang, & Erica K. Sloan. (2017). Paclitaxel induces memory impairment and anhedonia in mice. Brain Behavior and Immunity. 66. e1–e1. 1 indexed citations
17.
Chang, Aeson, Caroline P. Le, Adam K. Walker, et al.. (2016). β2-Adrenoceptors on tumor cells play a critical role in stress-enhanced metastasis in a mouse model of breast cancer. Brain Behavior and Immunity. 57. 106–115. 85 indexed citations
18.
Chang, Aeson, Corina Kim-Fuchs, Caroline P. Le, Frédéric Hollande, & Erica K. Sloan. (2015). Neural Regulation of Pancreatic Cancer: A Novel Target for Intervention. Cancers. 7(3). 1292–1312. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026